<DOC>
	<DOC>NCT01426035</DOC>
	<brief_summary>Evaluate the safety, tolerability and effectiveness of mucopolysaccharide polysulfate cream in the treatment of superficial varicose veins</brief_summary>
	<brief_title>Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate Cream In The Superficial Varicose Veins Treatment</brief_title>
	<detailed_description />
	<mesh_term>Varicose Veins</mesh_term>
	<criteria>Patients must be able to understand the study procedures, agree to participate, and give written consent. Patients must be able to follow the study medication regimen. Patients with inflammatory process in superficial veins for more than 72 hours. Presence of symmetric lesions to compare one side to the other. Pregnancy or risk of pregnancy. Lactation. Use of topical or systemic antiinflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study Any alteration at other deep veins. History of atopy or allergic diseases. History of allergy to any component of the formulations. Other conditions considered by the investigator as reasonable for noneligibility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>SUPERFICIAL VARICOSE VEINS</keyword>
</DOC>